CEPH - CEPHALON Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH - CEPHALON

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (25)	12/18/2002 4:58:20 PM
From: Icebrg	Read Replies (2) of 109

>>Dressing things up for a sale?>> No, I don't think so. To re-purchase European marketing rights for their own drugs seems to be a part of their strategy. Earlier during the autumn they "took back" Actiq from Elan. With their relatively strong base in Europe (France) this makes of course a lot of sense. Building up a critical mass of products in Europe should also be helpful if and when they take in new products. Their own pipeline looks IMHO relatively weak. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next